Table 3.
step | gene | disease | symptoms | patientsa | Chrb | mutation |
---|---|---|---|---|---|---|
1 | PIGA | PNHc | haemolysis, thrombosis | many | Xp | Sd in HSCe |
IGDf/MCAHSg | Szh, DD/IDi, Hptj | 26 | Gk | |||
1 | PIGC | IGD | Sz, DD/ID, Hpt | 2 | 1q | G |
1 | PIGH | IGD | Sz, DD/ID, Hpt | 2 | 14q | G |
1 | PIGP | IGD | Sz, DD/ID, Hpt | 2 | 21q | G |
1 | PIGQ | IGD | Sz, DD/ID, Hpt | 3 | 16p | G |
1 | PIGY | IGD | Sz, DD/ID, Hpt | 4 | 4q | G |
2 | PIGL | IGD, CHIME syndrome | Sz, DD/ID, Hpt | 15 | 17p | G |
4 | PIGW | IGD/HPMRSl | Sz, DD/ID, Hpt | 3 | 17q | G |
6 | PIGM | IGD | Sz, thrombosis | 7 | 1q | G, promotor |
7 | PIGV | IGD/HPMRS | Sz, DD/ID, Hpt | 18 | 1p | G |
8 | PIGN | IGD/MCAHS, Fryns syndrome | Sz, DD/ID, Hpt | 22 | 18q | G |
9 | PIGB | IGD/HPMRS | Sz, DD/ID, Hpt | 12 | 15q | G |
10 | PIGO | IGD/HPMRS | Sz, DD/ID, Hpt | 13 | 9p | G |
11 | PIGG | IGD | Sz, DD/ID, Hpt | 7 | 4p | G |
13 | GPAA1 | IGD | Sz, DD/ID, Hpt | 10 | 8q | G |
13 | PIGS | IGD | Sz, DD/ID, Hpt | 7 | 17p | G |
13 | PIGT | PIGT-PNH | haemolysis, thrombosis, inflam | 4 | 20q | G + S in HSC |
IGD/MCAHS | Sz, DD/ID, Hpt | 28 | G | |||
13 | PIGU | IGD | Sz, DD/ID, Hpt | 5 | 20q | G |
14 | PGAP1 | IGD | Sz, DD/ID, Hpt | 8 | 2q | G |
17 | PGAP3 | IGD/HPMRS | Sz, DD/ID, Hpt | 45 | 17q | G |
18 | PGAP2 | IGD/HPMRS | Sz, DD/ID, Hpt | 23 | 11p | G |
aNumbers of published patients as of December 2019.
bChr, chromosome location.
cPNH, paroxysmal nocturnal haemoglobinuria.
dS, somatic mutations.
eHSC, haematopoietic stem cell.
fIGD, inherited GPI deficiency.
gMCAHS, multiple congenital anomalies-hypotonia-seizures syndrome.
hSz, seizures.
iDD/ID, developmental delay/intellectual disability.
jHpt, hypotonia.
kG, germline mutations.
lHPMRS, hyperphosphatasia mental retardation syndrome/Mabry syndrome.
minfla, inflammation.